Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimaging the Impact of Respiration and Respiratory-gated Neuromodulation on Human Glymphatic Physiology

NCT05180981 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.

NCT NCT05180981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05180981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimaging the Impact of Respiration and Respiratory-gated Neuromodulation on Human Glymphatic Physiology
Lead sponsor
Boston University Charles River Campus
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 18, 2022
Completion date
November 30, 2026
Enrollment
81 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy